While others played safe, Shanghvi bet on complex generics and specialty pharma, and rode a wave of acquisitions to make Sun ...

In the latest episode of Inside Forbes India Podcast, Naini Thaker discusses her deep-dive profile on Dilip Shanghvi, the low ...

Ambani emerged as the biggest gainer during this period, with his net worth surging by nearly $20 billion from a March low of ...

Drugmakers breathed a sigh of relief Wednesday after President Trump didn’t announce pharmaceutical tariffs. Plus, language in the executive order indicated medicines were exempted from the ...